CORD-19:3c1f47a07aaf0e393dee9fbd08596a4b9f4f0a03 / 301072-301302 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T2318","span":{"begin":0,"end":230},"obj":"Sentence"},{"id":"T59642","span":{"begin":0,"end":230},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Compounds in late stage development include anti-MRSA b-lactams such as ceftobiprole, the broad-spectrum cephalosporin that has successfully completed two Phase III trials in complicated skin and skin structure infections (cSSSI)."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T54","span":{"begin":0,"end":230},"obj":"Sentence"}],"text":"Compounds in late stage development include anti-MRSA b-lactams such as ceftobiprole, the broad-spectrum cephalosporin that has successfully completed two Phase III trials in complicated skin and skin structure infections (cSSSI)."}

{"project":"CORD-19-PD-UBERON","denotations":[{"id":"T232","span":{"begin":187,"end":191},"obj":"Body_part"},{"id":"T233","span":{"begin":196,"end":200},"obj":"Body_part"}],"attributes":[{"id":"A232","pred":"uberon_id","subj":"T232","obj":"http://purl.obolibrary.org/obo/UBERON_0000014"},{"id":"A233","pred":"uberon_id","subj":"T233","obj":"http://purl.obolibrary.org/obo/UBERON_0000014"}],"text":"Compounds in late stage development include anti-MRSA b-lactams such as ceftobiprole, the broad-spectrum cephalosporin that has successfully completed two Phase III trials in complicated skin and skin structure infections (cSSSI)."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T1033","span":{"begin":49,"end":53},"obj":"Disease"},{"id":"T1034","span":{"begin":211,"end":221},"obj":"Disease"},{"id":"T89222","span":{"begin":49,"end":53},"obj":"Disease"},{"id":"T72352","span":{"begin":211,"end":221},"obj":"Disease"}],"attributes":[{"id":"A1033","pred":"mondo_id","subj":"T1033","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"},{"id":"A1034","pred":"mondo_id","subj":"T1034","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A21790","pred":"mondo_id","subj":"T89222","obj":"http://purl.obolibrary.org/obo/MONDO_0100073"},{"id":"A16448","pred":"mondo_id","subj":"T72352","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Compounds in late stage development include anti-MRSA b-lactams such as ceftobiprole, the broad-spectrum cephalosporin that has successfully completed two Phase III trials in complicated skin and skin structure infections (cSSSI)."}